| Literature DB >> 30316866 |
Shi Tang1, Lu Lu1, Lianqing Zhang1, Xinyu Hu1, Xuan Bu1, Hailong Li1, Xiaoxiao Hu1, Yingxue Gao1, Zirui Zeng2, Qiyong Gong3, Xiaoqi Huang4.
Abstract
BACKGROUND: Although dysfunction of amygdala-related circuits is centrally implicated in major depressive disorder (MDD), little is known about how this dysfunction differs between adult and adolescent MDD patients.Entities:
Keywords: Adolescents; Adults; Amygdala; Functional connectivity; Major depressive disorder; Meta-analysis
Mesh:
Year: 2018 PMID: 30316866 PMCID: PMC6197798 DOI: 10.1016/j.ebiom.2018.09.010
Source DB: PubMed Journal: EBioMedicine ISSN: 2352-3964 Impact factor: 8.143
Fig. 1Flowchart of the identification of articles. Abbreviations: ReHo, regional homogeneity; ALFF, amplitude of low-frequency fluctuation; ICA, independent components analysis; fALFF, fractional ALFF; PD, Parkinson's disease.
Demographic and clinical characteristics of the studies included in this meta-analysis.
| Study | MDD subjects | HC | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Mean age (SD), years | Female, N (%) | Mean illness duration (SD), years | Depression state | Depression severity | Medication status (%) | Comorbidity (N) | N | Mean age (SD), years | Female (N, %) | |
| Samples from adolescents | |||||||||||
| Kim et al., 2015 [ | 22 | 13.9(1.6) | 8(36) | 6(1.6) | Active | CDI: 40.0 | Medication-naïve (100%) | Pure MDD | 20 | 14.5(1.7) | 6(30) |
| Pannekoek et al., 2014 [ | 26 | 15.4(1.5) | 23(88) | NA | Active | CDI: 18.6 | Medication-naïve (100%) | Anxiety (18) | 26 | 14.7(1.5) | 23(88.5) |
| Peters et al., 2016 [ | 23 | 15.61(1.9) | 13(57) | NA | Remitted | CDRS-R: 26.91 | Medicated (52%) | Anxiety (8) | 10 | 15.8(1.99) | 7(70) |
| Chattopadhyay et al., 2017 [ | 82 | 15.69(1.12) | 64(78) | NA | Active | SMFQ: 18.02 | Medication-naïve (100%) | Pure MDD | 34 | 15.73(1.44) | 27(100) |
| Cullen et al., 2014 [ | 41 | 15.7(2) | 32(78) | 0.83(0.9) | Active | CRDS: 77 | Medication-naïve (73%) | Anxiety (25) | 29 | 16(2) | 22(76) |
| Connolly et al., 2017 [ | 48 | 16.1(1.3) | 29(60) | NA | Active | CRDS: 70.2 | Medication-naïve (100%) | Anxiety (14), PTSD (5) | 53 | 16.1(1.3) | 33(62) |
| Cullen et al., 2009 [ | 12 | 16.5(0.95) | 9(75) | 2.2(2.2) | Active | CRDS: 77 | Medicated (84%) | Anxiety (10) | 14 | 16.8(1.5) | 8(57) |
| Straub et al., 2017 [ | 19 | 16.76(1.39) | 15(79) | NA | Active | CRDS: 55.91 | Drug-free | Phobia (5) | 19 | 16.35(1.47) | 15(79) |
| Samples from adults | |||||||||||
| Zhang X et al., 2014 [ | 32 | 20.53(1.78) | 18(56) | NA | Active | CES-D: 38.03 | Medication-naïve (100%) | Pure MDD | 35 | 20.97(1.29) | 17(49) |
| Jacobs et al., 2016(a) [ | 17 | 22.35(1.80) | 11(65) | 3.13 | Active | HAMD: 18.65 | Medicated (36%) | Anxiety (15) | 26 | 21.15(1.49) | 14(54) |
| Jacobs et al., 2016(b) [ | 34 | 21.06(1.54) | 25(74) | 7.97 | Remitted | HAMD: 2.35 | Medicated (62%) | Anxiety (12) | 26 | 21.15(1.49) | 14(54) |
| Ye J et al., 2017 (YA) [ | 34 | 24.15(2.84) | 17(50) | NA | Active | HAMD: 23.59 | Medication-naïve (100%) | Pure MDD | 35 | 24.8(2.14) | 18(51) |
| Altinay et al., 2016 [ | 15 | 27(10) | 9(60) | NA | Active | HAMD: 20 | Drug-free | Anxiety (15), PTSD (1) | 15 | 29(8) | 9(60) |
| Deligiannidis et al., 2013 [ | 8 | 28.62(5.93) | 8(100) | NA | Active | QIDS: 11.3 | Drug-free | Anxiety (4), PTSD (1) | 9 | 30.67(3.81) | 9(100) |
| Tang Y et al., 2013 [ | 28 | 29.3(8.7) | 16(57) | 1.13(1.3) | Active | HAMD: 29 | Medication-naïve (100%) | Pure MDD | 30 | 30.1(8.4) | 15(50) |
| Lui S et al., 2011 (NRD) [ | 32 | 32(10) | 11(34) | 1.83(1.5) | Active | HAMD: 23.0 | Medication-naïve (100%) | Pure MDD | 48 | 35(12) | 17(35) |
| Wang Y et al., 2016 [ | 25 | 32.11(11.25) | 11(44) | 0.7(0.2) | Active | HAMD: 29.32 | NA | Pure MDD | 35 | 33.28(8.83) | 16(46) |
| Lui S et al., 2011 (RD)[ | 28 | 33(11) | 10(37.5) | 16.08(10) | Active | HAMD: 23.3 | Medication-naïve (100%) | Pure MDD | 48 | 35(12) | 17(35) |
| Ramasubbu et al., 2014 [ | 55 | 36.5(10.4) | 33(60) | 4.19(5) | Active | HAMD: 21.41 | Drug-free | Pure MDD | 19 | 32.89(9.97) | 11(58) |
| Ye J et al., 2017 (OA)[ | 35 | 37.14(4.15) | 26(74) | NA | Active | HAMD: 23.69 | Medication-naïve (100%) | Pure MDD | 46 | 37.22(4.44) | 36(78) |
| Yang J et al., 2017 [ | 35 | 44.54(11.15) | 35(100) | 2.68(3.8) | Active | HAMD: 28.29 | Drug-free | Pure MDD | 23 | 39.09(14.3) | 23(100) |
| Tahmasian et al., 2013 [ | 21 | 51(15) | 11(52) | 14.7(11) | Active | HAMD: 23.8 | Medicated (95%) | Anxiety (6),somatization disorder (2),personality disorder (5) | 20 | 49.6(13.9) | 11(55) |
Abbreviations: N, numbers; CDI, Children's Depression Inventory; CDRS-R, Children's Depression Rating Scale-Revised; CDRS, Children's Depression Rating Scale; SMFQ, Short Mood and Feeling Questionnaire; CES-D, Center for Epidemiological Studies Depression Scale; HAMD, Hamilton Rating Scale for Depression; QIDS, Quick Inventory Depressive Symptoms; NA, not available; YA, young adult; NRD, nonrefractory depression; RD, refractory depression; OA, older adults.
Fig. 2Results of amygdala rsFC meta-analysis for, from top to bottom, adult patients with major depressive disorder (MDD) relative to healthy controls (HC); adolescent patients with MDD relative to HC (red, MDD patients>HC; blue, MDD patients
Meta-analysis results regarding regional differences in amygdala rsFC.
| Local maximum | Cluster | Jackknife sensitivityanalysis | ||||
|---|---|---|---|---|---|---|
| Region | MNI coordinates | SDM-Z | p value | No. of voxels | Breakdown (no. of voxels) | |
| Adult MDD vs. HC (No. of datasets: 14) | ||||||
| Hyperconnectivity (MDD > HC) | ||||||
| R-parahippocampal gyrus | 26,0, −32 | 1.639 | <0.0001 | 1206 | R-parahippocampal gyrus (391) | 14 out of 14 |
| R-hippocampus (199) | ||||||
| R-amygdala (215) | ||||||
| R-fusiform gyrus (257) | ||||||
| R-temporal pole (144) | ||||||
| R-vmOFC | 8,32, −20 | 1.367 | <0.001 | 434 | R-vmOFC (325) | 13 out of 14 |
| L-vmOFC (39) | ||||||
| R-SFG (60) | ||||||
| Hypoconnectivity (MDD < HC) | ||||||
| R-insula | 54,4,2 | −2.588 | <0.000005 | 1981 | R-insula (1070) | 14 out of 14 |
| R- IFG, pars opercularis (343) | ||||||
| R-IFG, pars triangularis (441) | ||||||
| R-temporal pole/STG (137) | ||||||
| L-insula | −46,20, −8 | −2.235 | <0.00005 | 1292 | L-insula (498) | 14 out of 14 |
| L-IFG, pars orbitalis (327) | ||||||
| L- temporal pole, STG (293) | ||||||
| L-IFG, pars opercularis (89) | ||||||
| L-IFG, pars triangularis (85) | ||||||
| L-caudate nucleus | −10, −6, 16 | −1.831 | <0.001 | 137 | L-caudate nucleus (100) | 12 out of 14 |
| L-thalamus (37) | ||||||
| L-cerebellum | −32, −66, −48 | −1.551 | <0.005 | 261 | L-cerebellum (261) | 13 out of 14 |
| Adolescent MDD vs. HC (no. of datasets: 8) | ||||||
| Hyperconnectivity (MDD > HC) | ||||||
| R-precuneus | 10, −70, 26 | 1.528 | <0.001 | 388 | R-precuneus (152) | 7 out of 8 |
| R-cuneus cortex (96) | ||||||
| R-calcarine fissure (89) | ||||||
| L-precuneus (18) | ||||||
| L-cuneus cortex (12) | ||||||
| L-calcarine fissure (17) | ||||||
| R-IFG, pars opercularis | 34,12,30 | 1.719 | <0.0005 | 192 | R-IFG, pars opercularis (135) | 7 out of 8 |
| R-IFG, pars triangularis (57) | ||||||
| Hypoconnectivity (MDD < HC) | ||||||
| L-DLPFC | −24,64,12 | −1.34 | <0.0005 | 306 | L-DLPFC (246) | 7 out of 8 |
| L-MFG (60) | ||||||
| R-ITG | 52, −30, −30 | −1.033 | <0.005 | 142 | R-ITG (117) | 7 out of 8 |
| R-fusiform gyrus (25) | ||||||
| Adult MDD (vs. HC) vs. adolescent MDD (vs. HC) | ||||||
| Adult MDD > adolescent MDD | ||||||
| R-parahippocampal gyrus | 26,2, −32 | 1.299 | <0.0005 | 503 | R-parahippocampal gyrus (190) | |
| R-hippocampus (100) | ||||||
| R-amygdala (115) | ||||||
| R-fusiform gyrus (28) | ||||||
| R-temporal pole (70) | ||||||
| R-ITG | 52, −30, −30 | 1.15 | <0.001 | 276 | R-ITG (217) | |
| R-fusiform gyrus (59) | ||||||
| Adult MDD < adolescent MDD | ||||||
| R-insula | 52,4,0 | −2.307 | <0.0001 | 2232 | R-insula (742) | |
| R-rolandic operculum (393) | ||||||
| R-IFG, pars triangularis (491) | ||||||
| R-IFG, pars opercularis(479) | ||||||
| R-temporal pole/STG (137) | ||||||
| L-insula | −40,18, −12 | −1.593 | <0.005 | 122 | L-insula (62) | |
| L-IFG, pars orbitalis (60) | ||||||
Abbreviations: rsFC, resting-state functional connectivity; MDD, major depressive disorder; HC, healthy controls; MNI, Montreal Neurological Institute; SDM, signed differential mapping; L, left; R, right; DLPFC, dorsal lateral prefrontal gyrus; vmOFC, ventromedial orbital frontal cortex; SFG, superior frontal gyrus; MFG, middle frontal gyrus; IFG, inferior frontal gyrus; STG, superior temporal gyrus; ITG, inferior temporal gyrus.
Fig. 3Meta-regression results showing that the age of adult MDD patients is negatively correlated with the rsFC in the right insula (peak voxel coordinate: 50, 14, −2, r = 0.604, p < 0.0001). In the graphs, the effect sizes needed to create this plot have been extracted from the peak of the maximum slope significance, and each dataset is represented as a dot, whose size reflects the sample size. Large dots indicate samples with 20–40 patients, and small dots represent samples with <20 patients. The regression line (meta-regression signed differential mapping slope) is shown.